Hardy Alexander 4
4 · BIOMARIN PHARMACEUTICAL INC · Filed Dec 5, 2023
Insider Transaction Report
Form 4
Hardy Alexander
DirectorChief Executive Officer
Transactions
- Award
Common Stock
2023-12-01+68,039→ 68,039 total - Award
Common Stock
2023-12-01+47,332→ 115,371 total - Award
Stock Option (Right to Buy Common Stock)
2023-12-01+150,529→ 150,529 totalExercise: $92.42From: 2024-12-01Exp: 2033-11-30→ Common Stock (150,529 underlying)
Footnotes (2)
- [F1]Restricted stock units granted on December 1, 2023. Price not applicable.
- [F2]Option grant vests 12/48th on December 1, 2024 and 1/48th on the 1st day of each month thereafter.